Best Monoamine Oxidase Inhibitor for alzheimer disease
2 Monoamine Oxidase Inhibitor drugs indicated for alzheimer disease, ranked by our independent rating. The current highest-rated is emsam. Compare them with all treatments for alzheimer disease or the full Monoamine Oxidase Inhibitor class. Not medical advice — always consult a professional.
Top monoamine oxidase inhibitor for alzheimer disease: 1. Emsam · 2. Zelapar
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Emsam | Not yet rated | Prescription | $19 | View → |
| 2 | Zelapar | Not yet rated | Prescription | $19 | View → |
Full ranking · 2 drugs
emsam
PrescriptionFDA-sourced
Selegiline hydrochloride is a levorotatory acetylenic derivative of phenethylamine.
monoamine oxidase inhibitormonoamine oxidase type b inhibitoralzheimer disease
Typical price
From ~$19.10/30· 2 formsFrequently asked
- What is the best monoamine oxidase inhibitor for alzheimer disease?
- By our independent rating, emsam currently ranks highest among Monoamine Oxidase Inhibitor drugs used for alzheimer disease. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which monoamine oxidase inhibitor drugs treat alzheimer disease?
- pharmaranks lists 2 Monoamine Oxidase Inhibitor products indicated for alzheimer disease, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.